A qualitative immunochemistry analysis of Plexin-B3 expression in the KC pancreatic tumor progression model shows an initial increase of Plexin-B3 staining until 20 weeks, followed by a decrease in Plexin-B3 expression in later stages. Here, PLXNB3 is linked to pancreatic neoplasm.